Beam Therapeutics Insider Sold Shares Worth $1,188,745, According to a Recent SEC Filing

MT newswire2026/10/19 08:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:07 AM EDT, 10/19/2026 (MT Newswires) -- John M. Evans, Director, Chief Executive Officer, on October 15, 2026, sold 50,000 shares in Beam Therapeutics (BEAM) for $1,188,745. Following the Form 4 filing with the SEC, Evans has control over a total of 1,150,205 shares of the company, with 1,047,205 shares held directly and 103,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1745999/000119312526424421/xslF345X05/ownership.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The Housing Market Index, jointly released by the National Association of Home Builders (NAHB) and Wells Fargo, fell by 3 points this month to 29, the lowest level since June 2012 and below the market expectation of 31. The sales sub-index dropped to 33, also a 14-year low; the index for expected sales over the next six months declined to its weakest level since November 2022; the index measuring potential buyer traffic fell to its lowest point since the onset of the COVID-19 pandemic.

华尔街见闻•2026/10/19 15:16